The Report “Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) -Forecast to 2019” is expected to reach a value of $573.3 Million by 2019, estimated to grow at a CAGR of 13.8% from 2014 to 2019
Browse through the TOC of Asian Internal Neurostimulaiton/Neuromodulation Market for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on reports.
This report studies the Asia-Pacific Internal Neuromodulation devices market for the forecast period between 2014 and 2019. The market is estimated to reach ~$573.3 million by 2019, at CAGR of 13.8% between 2014 and 2019.
The Asia-Pacific Internal Neuromodulation market is classified into five main modalities, Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Gastric Neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain, and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while the Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes Gastroparaeisis and others.
Several factors, such as growing public and private initiatives to increase awareness, rising incidences of neurological diseases, increasing demand for advanced technologies, government investments and rapid growth in aging population are driving the growth of the Internal Neuromodulation market. On the other hand lack of trained professionals and unfavorable re-imbursement scenario are restricting the growth of the market.
As of 2014, Japan is estimated to hold the largest share of the Asia-Pacific Internal Neuromodulation market, followed by China. However, the India market is projected to register the highest CAGR of 15.3% between 2014 and 2019. Several factors, including rising incidences of neurological disorder, increasing focus on adaption of advanced technologies, and development of healthcare infrastructure are stimulating the growth of the internal neuromodulation market in the Asia-Pacific region.
Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) are the leading players in the Asia-Pacific Internal Neuromodulation market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013,
India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com
